AbbVie Inc. — Earnings Release 2016

Jan 29, 2016

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the*

*Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): January 29, 2016

*ABBVIE INC.*

(Exact name of registrant as specified in its charter)

Delaware	001-35565	32-0375147
(State or other Jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification No.)

*1 North Waukegan Road*

*North Chicago, Illinois 60064-6400*

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (847) 932-7900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\108750\16-2967-1\task7752745\2967-1-ba.htm',USER='108750',CD='Jan 29 06:49 2016'

*Item 2.02. Results of Operations and Financial Condition*

On January 29, 2016, AbbVie Inc. issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2015. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

*Item 9.01 Financial Statements and Exhibits*

Exhibit No.	Exhibit
99.1	Press Release dated January 29, 2016 (furnished pursuant to Item 2.02).

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\108750\16-2967-1\task7752745\2967-1-ba.htm',USER='108750',CD='Jan 29 06:49 2016'

*SIGNATURE*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ABBVIE INC. — /s/ William J. Chase
William J. Chase
Executive Vice President,
Chief Financial Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\108750\16-2967-1\task7752745\2967-1-ba.htm',USER='108750',CD='Jan 29 06:49 2016'

*EXHIBIT INDEX*

Exhibit No.	Exhibit
99.1	Press Release dated January 29, 2016 (furnished pursuant to Item 2.02).

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\108750\16-2967-1\task7752745\2967-1-ba.htm',USER='108750',CD='Jan 29 06:49 2016'